(Total Views: 108)
 Posted On: 04/26/2023 1:58:10 PM 
  
		  		    Post#  of 45054		    
			
		      
  
	$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology. 
 	
 
 (0)
(0) (0)
(0)
       Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
  
    
      
    
   
      			












